Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
13 pending office actions • 9 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
The University of Melbourne has 13 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 9 distinct art units, reflecting a broad range of research within the life sciences. The prosecution involves 13 distinct examiners, meaning each of the 13 pending actions is being reviewed by a different individual. This distribution requires the university to navigate the individual styles of many different examiners to advance its 13 pending matters.
BASIL T JOS is the busiest examiner for the portfolio, with 1 pending office action currently under review. This reflects a perfectly distributed workload where no examiner is handling more than one case for the university. The high number of 9 distinct art units for only 13 pending actions suggests that the university's innovations are highly specialized and spread across many different technical classifications. Practitioners should note that the busiest examiner handles 1 of the active matters, which is consistent with the overall distribution of the portfolio. The focus on Biotechnology & Pharmaceuticals ensures that the prosecution remains within a specific technical framework. With 13 pending office actions, the university maintains a steady and distributed presence at the patent office.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (31%) |
| §102 only | 1 (8%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 6 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOS, BASIL T | 1 | 78.0% | +6.2% |
| LEE, SIN J | 1 | 68.8% | +25.1% |
| BERTRAM, ERIC D | 1 | 81.2% | +12.4% |
| STOCK JR, GORDON J | 1 | 81.5% | +17.5% |
| VIGIL, TORIANA NICHOLE | 1 | 53.1% | +24.1% |
| HANEY, JONATHAN MICHAEL | 1 | 56.6% | +53.3% |
| BOATENG, AFUA BAMFOAA | 1 | 46.6% | +64.4% |
| OGUNTADE, ELIZABETH BISOLA | 1 | 0.0% | +0.0% |
| O'KEEFE, SEAN P | 1 | 65.7% | +12.5% |
| JOHNSON, NICOLE F | 1 | 87.4% | +7.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18024154 | LASER METHOD, DEVICE AND SYSTEM FOR TREATING RETINAL DETACHMENT | JOHNSON, NICOLE F | 84d overdue |
| 18949065 | METHODS, SYSTEMS, AND APPARATUS FOR CLOSED-LOOP NEUROMODULATION | BERTRAM, ERIC D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17922583 | COPPER-CONTAINING THERAGNOSTIC COMPOSITIONS AND METHODS OF USE | DONOHUE, SEAN R | 15d overdue |
| 18766377 | EVANESCENT FIELD RESONANCE IMAGING MICROSCOPY APPARATUS AND METHOD | STOCK JR, GORDON J | — |
| 18714285 | NOVEL POLYMER | VIGIL, TORIANA NICHOLE | — |
| 18699932 | BLOOD COLLECTION DEVICE | HANEY, JONATHAN MICHAEL | — |
| 18562459 | METHODS FOR INDUCING VASODILATION | BOATENG, AFUA BAMFOAA | — |
| 18285490 | MULTIPLEX IMMUNOASSAY FOR THE DETECTION OF MYCOPLASMA BOVIS INFECTION | OGUNTADE, ELIZABETH BISOLA | — |
| 18462923 | LIQUID PHASE SINTERED ALUMINUM ALLOY FOR BINDER JET PRINTING | O'KEEFE, SEAN P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19028247 | COMPLEXES FOR TREATING SENSITIVITY | LEE, SIN J | — |
| 18949065 | METHODS, SYSTEMS, AND APPARATUS FOR CLOSED-LOOP NEUROMODULATION | BERTRAM, ERIC D | — |
| 18766377 | EVANESCENT FIELD RESONANCE IMAGING MICROSCOPY APPARATUS AND METHOD | STOCK JR, GORDON J | — |
| 18714285 | NOVEL POLYMER | VIGIL, TORIANA NICHOLE | — |
| 18699932 | BLOOD COLLECTION DEVICE | HANEY, JONATHAN MICHAEL | — |
| 18562459 | METHODS FOR INDUCING VASODILATION | BOATENG, AFUA BAMFOAA | — |
| 18462923 | LIQUID PHASE SINTERED ALUMINUM ALLOY FOR BINDER JET PRINTING | O'KEEFE, SEAN P | — |
| Art Unit | Apps |
|---|---|
| 1612 | 2 |
| 2877 | 1 |
| 3791 | 1 |
| 1617 | 1 |
| 1677 | 1 |
| 1738 | 1 |
| 3796 | 1 |
| 1618 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19175898 | MEDICAL DEVICE FOR SENSING AND OR STIMULATING TISSUE | JOS, BASIL T | — | §103 | Non-Final OA | — | Pending | Apr 10, 2025 |
| 19028247 | COMPLEXES FOR TREATING SENSITIVITY | LEE, SIN J | — | §103DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18949065 | METHODS, SYSTEMS, AND APPARATUS FOR CLOSED-LOOP NEUROMODULATION | BERTRAM, ERIC D | — | §102 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18766377 | EVANESCENT FIELD RESONANCE IMAGING MICROSCOPY APPARATUS AND METHOD | STOCK JR, GORDON J | 2877 | §102§103§112Other | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18714285 | NOVEL POLYMER | VIGIL, TORIANA NICHOLE | 1612 | §103§112 | Non-Final OA | — | Pending | May 29, 2024 |
| 18699932 | BLOOD COLLECTION DEVICE | HANEY, JONATHAN MICHAEL | 3791 | §102§103§112 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18562459 | METHODS FOR INDUCING VASODILATION | BOATENG, AFUA BAMFOAA | 1617 | §102§103§112Other | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18285490 | MULTIPLEX IMMUNOASSAY FOR THE DETECTION OF MYCOPLASMA BOVIS INFECTION | OGUNTADE, ELIZABETH BISOLA | 1677 | §102§103§112DP | Non-Final OA | — | Pending | Oct 03, 2023 |
| 18462923 | LIQUID PHASE SINTERED ALUMINUM ALLOY FOR BINDER JET PRINTING | O'KEEFE, SEAN P | 1738 | §102§103 | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18024154 | LASER METHOD, DEVICE AND SYSTEM FOR TREATING RETINAL DETACHMENT | JOHNSON, NICOLE F | 3796 | §103 | Final Rejection | 84d overdue | Pending | Mar 01, 2023 |
| 17922583 | COPPER-CONTAINING THERAGNOSTIC COMPOSITIONS AND METHODS OF USE | DONOHUE, SEAN R | 1618 | §103§112 | Non-Final OA | 15d overdue | Pending | Oct 31, 2022 |
| 17620147 | ANTIMICROBIAL PEPTIDE-SELENIUM NANOPARTICLES | GOTFREDSON, GAREN | 1619 | §103 | Non-Final OA | 35d | Pending | Dec 17, 2021 |
| 17438299 | CONCEALMENT OF HYPOMINERALISED LESIONS | ROBERTS, LEZAH | 1612 | §103Other | Non-Final OA | 3d overdue | Pending | Sep 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial